PHARMACOLOGICAL STUDY ON L-ORNITHINE L-ASPARTATE
スポンサーリンク
概要
- 論文の詳細を見る
In a healthy subject, ammonia produced in the body is excreted by the kidney in the form of urea, the product of the urea cycle (1), or converted into substances useful for the body.<BR> In cases of hepatic disorders, on the other hand, blood ammonia level is known to increase (2-6). It is likely that ammonia in high concentrations interferes with the TCA cycle (7) and thus disturbs the completion of carbohydrate and protein metabolism so seriously as to cause inhibition of ATP synthesis and the subsequent liability or aggravation of fatty degeneration of the liver. It is also possible that the impaired brain metabolism due to elevated blood ammonia is liable to cause disturbance of consciousness or to precipitate coma.<BR> Varieties of treatments lowering the elevated blood level of ammonia have been reported to be effective in relieving the symptoms and improving the pathological conditions of ammonia intoxication. Greenstein <I>et al</I>. (8, 9) and other workers (10-12) dealt with L-arginine ; White and Berenbom (13) and other workers (14-17) studied L-glutamic acid; and Laborit <I>et al</I>. (18-20), Fodor <I>et al</I>. (21), and Tamaki <I>et al</I>. (22) examined Laspartic acid. The findings of these authors support the usefulness of three compounds in reducing the blood level of ammonia, and all three compounds are enjoying clinical use. One may point out the important role of L-ornithine in metabolic process in the body, if he appreciates the critical function of the urea cycle and the TCA cycle. Salvatore and Bocchini (23) obtained an excellent result with concomitant use of Laspartic acid and L-ornithine in protecting the toxic effect of ammonium acetate as compared with the use of L-aspartic acid alone. Salvatore <I>et al</I>. (24, 25) also reported the superiority of the combined medication in chronic intoxication of carbon tetrachloride.<BR> The present paper is concerned with general pharmacology of L-ornithine L-aspartate and effects of the compound upon ammonia and carbon tetrachloride intoxications.
- 公益社団法人 日本薬理学会の論文
著者
-
塩屋 明利
Department of Pharmacology, Division of Biology, Research Laboratories, Chugai Pharmaceutical Co., L
-
柿本 守夫
Department of Pharmacology, Division of Biology, Research Laboratories, Chugai Pharmaceutical Co., L
-
倉石 弘一
Department of Pharmacology, Division of Biology, Research Laboratories, Chugai Pharmaceutical Co., Ltd.
-
玉真 洋子
Department of Pharmacology, Division of Biology, Research Laboratories, Chugai Pharmaceutical Co., Ltd.
関連論文
- 2, 5-DI-O-ACETYL-D-GLUCOSACCHARO-(1→4), (6→3)-DILACTONE, A NEW POTENT β-GLUCURONIDASE INHIBITOR
- SERUM β-GLUCURONIDASE AND β-ACETYLGLUCOSAMINASE ACTIVITIES IN EXPERIMENTAL DIABETIC RABBITS
- A PHOTOELECTRIC METHOD FOR ESTIMATING INFLAMMATORY INTENSITY IN MICE AND ITS APPLICATION TO THE ANTI-INFLAMMATORY EVALUATION OF GLUCURONIC ACID DERIVATIVES
- SERUM β-GLUCURONIDASE ACTIVITY FOLLOWING THE ADMINISTRATION OF VARIOUS SUGARS AND ANTIDIABETICS IN RABBITS
- THE RELATIONSHIP BETWEEN SERUM β-GLUCURONIDASE ACTIVITY AND BLOOD SUGAR LEVEL
- PHARMACOLOGICAL STUDY ON L-ORNITHINE L-ASPARTATE
- PHARMACOLOGICAL PROPERTIES OF 3-(p-CHLOROBENZYL) QUINOLIZIDINE TARTARATE (QB-1), A NEW OXYTOCIC